SMAD2 and Hepatic fibrosis: Additionally, research by Peng Qi indicated that GDF-15 plays a profibrotic role in liver fibrosis in mice via the TGF-β/Smad2/3 pathway, proposing that inhibiting GDF-15 may serve as a viable treatment approach for alleviating fibrosis and delaying HSC activation [10].